Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Harald Aarseth

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|March 29, 2020
High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950-2018Johannes Sverre Willumsen, Jan Harald Aarseth, Kjell-Morten Myhr, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 31, 2010
How long can you keep working with benign multiple sclerosis?Solveig B Glad, Harald Nyland, Jan Harald Aarseth, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 28, 2024
BCG vaccination and multiple sclerosis risk: A Norwegian cohort studyOla Nakken, Jan Harald Aarseth, Stig Wergeland, et al.
Acta Neurologica Scandinavica|December 15, 2010
Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern NorwayGeir Risberg, Jan Harald Aarseth, Harald Nyland, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2004
Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in NorwayIngfrid Salvesen Haldorsen, Jan Harald Aarseth, Aase Hollender, et al.
Mitochondrion|December 27, 2016
Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosisKristin N Varhaug, Christian A Vedeler, Kjell-Morten Myhr, et al.
Multiple Sclerosis and Related Disorders|August 31, 2025
Effect of early highly effective treatment compared to an escalating treatment strategy in multiple sclerosisHilde Norborg, Jan Harald Aarseth, Janne Mannseth, et al.
Multiple Sclerosis and Related Disorders|February 26, 2023
Predictors of hospitalization due to infection in rituximab-treated MS patientsJakob Rishovd Karlowicz, Mattias Klakegg, Jan Harald Aarseth, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Early extended interval dosing of rituximab in multiple sclerosis: A comparative cohort study on efficacy and safetyMaria Therese Fossum, Hilde Marie Torgauten, Jan Harald Aarseth, et al.
Journal of Neuro-Oncology|November 25, 2018
Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IVKristin Marie Knudsen-Baas, Tom Børge Johannesen, Tor Åge Myklebust, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Neurology(R) Neuroimmunology & Neuroinflammation|March 29, 2020
High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950-2018Johannes Sverre Willumsen, Jan Harald Aarseth, Kjell-Morten Myhr, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 31, 2010
How long can you keep working with benign multiple sclerosis?Solveig B Glad, Harald Nyland, Jan Harald Aarseth, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 28, 2024
BCG vaccination and multiple sclerosis risk: A Norwegian cohort studyOla Nakken, Jan Harald Aarseth, Stig Wergeland, et al.
Acta Neurologica Scandinavica|December 15, 2010
Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern NorwayGeir Risberg, Jan Harald Aarseth, Harald Nyland, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2004
Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in NorwayIngfrid Salvesen Haldorsen, Jan Harald Aarseth, Aase Hollender, et al.
Mitochondrion|December 27, 2016
Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosisKristin N Varhaug, Christian A Vedeler, Kjell-Morten Myhr, et al.
Multiple Sclerosis and Related Disorders|August 31, 2025
Effect of early highly effective treatment compared to an escalating treatment strategy in multiple sclerosisHilde Norborg, Jan Harald Aarseth, Janne Mannseth, et al.
Multiple Sclerosis and Related Disorders|February 26, 2023
Predictors of hospitalization due to infection in rituximab-treated MS patientsJakob Rishovd Karlowicz, Mattias Klakegg, Jan Harald Aarseth, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Early extended interval dosing of rituximab in multiple sclerosis: A comparative cohort study on efficacy and safetyMaria Therese Fossum, Hilde Marie Torgauten, Jan Harald Aarseth, et al.
Journal of Neuro-Oncology|November 25, 2018
Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IVKristin Marie Knudsen-Baas, Tom Børge Johannesen, Tor Åge Myklebust, et al.
Pageof 2